Intralesional Targeted Alpha Therapy for Metastatic Melanoma
The paper reports the development and application of intralesional targeted alpha therapy (TAT) for melanoma, being the first part of a program to establish a new systemic therapy.
ALLEN Barry J.;
RAJA C.;
RIZVI S.M.A.;
LI Y.;
TSUI W.;
GRAHAM P.;
THOMPSON J.;
REISFELD R.A.;
KEARSLEY J.;
MORGENSTERN Alfred;
APOSTOLIDIS Christos;
2006-06-01
LANDES BIOSCIENCE
JRC33607
https://publications.jrc.ec.europa.eu/repository/handle/JRC33607,
Additional supporting files
| File name | Description | File type | |
|---|
